Roche Diagnostics President Emea-Latam Dr. Michael Heuer and Dr. Ibrahim Alomar, Vice President for Laboratories Affairs at Dr Sulaiman Al Habib Medical Group, with other company executives, during the signing of agreement at the Arab Health Exhibition.

RIYADH – Dr Sulaiman Al Habib Medical Group signed an agreement to install Roche Diagnostics Total Lab Automization (TLA) solutions at four leading hospitals in Riyadh. The deal was signed at the Arab Health Exhibition & Congress.



Furthering the advancement of modern healthcare, Roche Diagnostics TLA solutions provide an exceptionally high level of quality and continuity in the laboratory. This means reduced manual intervention during the diagnostic process, in turn this significantly minimizing the element of human error occurring.



The signing ceremony was attended by Roche Diagnostics President Emea-Latam Dr. Michael Heuer and Dr. Ibrahim Alomar, Vice President for Laboratories Affairs at Dr Sulaiman Al Habib Medical Group.



Commenting at the ceremony, Dr. Heuer said “this ground-breaking deal embodies our commitment to providing innovative healthcare solutions to the private and public sector as well as being a testimony to the importance the KSA market holds for us. What better way to evidence this than through joining forces with one of the largest providers of comprehensive healthcare services in the region – Dr Sulaiman Al Habib Medical Group.”



Dr. Alomar said “we are confident that Roche Diagnostics’ broad range of innovative diagnostic tests and systems will play a pivotal role in the advancement of integrated healthcare solutions offered at Dr Sulaiman Al Habib Medical Group and cover the early detection, targeted screening, evaluation and monitoring of disease.”



Roche Diagnostics is active in all market segments, from scientific research and clinical laboratory systems to patient self-monitoring. — SG